The Patent Finder

SmithKline Beecham Laboratories Pharmaceutiques

Also on record
Records under this name other than patents SmithKline Beecham Laboratories Pharmaceutiques holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to SmithKline Beecham Laboratories Pharmaceutiques

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,274,172Therapeutic effervescent compositions
Formerly held
Term ended
Term ended Sep 3, 2018 · USPTO record
Term endedTerm ended Sep 3, 2018USPTO record
US 6,506,758Indole Derivatives Useful A.O. for the Treatment of Osteoporosis
Lapsed on the fee record
Ended Jan 14, 2015 · Medium confidence
Lapsed on the fee recordEnded Jan 14, 2015Medium confidence
US 6,316,219Compounds
Lapsed on the fee record
Ended Nov 13, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2013USPTO record
US 6,200,776Polynucleotides encoding human sodium bicarbonate cotransporters
Lapsed on the fee record
Ended Mar 13, 2013 · USPTO record
Lapsed on the fee recordEnded Mar 13, 2013USPTO record
US 6,197,069Adrenomedullin receptor polynucleotides
Lapsed on the fee record
Ended Mar 6, 2013 · USPTO record
Lapsed on the fee recordEnded Mar 6, 2013USPTO record
US 6,780,875Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
Lapsed on the fee record
Ended Aug 24, 2012 · USPTO record
Lapsed on the fee recordEnded Aug 24, 2012USPTO record
US 6,096,517Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
Lapsed on the fee record
Ended Aug 1, 2012 · USPTO record
Lapsed on the fee recordEnded Aug 1, 2012USPTO record
US 6,699,889Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
Lapsed on the fee record
Ended Mar 2, 2012 · USPTO record
Lapsed on the fee recordEnded Mar 2, 2012USPTO record
US 6,613,770Quinoline derivatives as NK-2 and NK-3 receptor ligands
Lapsed on the fee record
Ended Sep 2, 2011 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2011USPTO record
US 6,570,037Nitro-benzamides useful as anti-arrhythmic agents
Lapsed on the fee record
Ended May 27, 2011 · USPTO record
Lapsed on the fee recordEnded May 27, 2011USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited